STOCK TITAN

Evolus to Participate in November Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Evolus, Inc. (NASDAQ: EOLS), a company focused on beauty products, is participating in two investment conferences in November 2022. The first event is the Stifel 2022 Healthcare Conference on November 15, 2022, from 8:35-9:05 am ET. The second event is the 5th Annual Evercore ISI HealthCONx Conference on November 30, 2022, from 11:45-12:05 pm ET. Audio webcasts of both events will be available on Evolus’ investor relations website, with replays accessible for 90 days.

Positive
  • None.
Negative
  • None.

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating in two investment conferences in November.

Event:

 

Stifel 2022 Healthcare Conference

Date:

 

Tuesday, November 15, 2022

Time:

 

8:35-9:05 am ET

 

Event:

 

5th Annual Evercore ISI HealthCONx Conference

Date:

 

Wednesday, November 30, 2022

Time:

 

11:45-12:05 pm ET

Audio webcasts of these events will be available on the investor relations section of Evolus’ website at www.evolus.com. Replays of the webcasts will be available for 90 days after the date of the presentation.

About Evolus, Inc.

Evolus (Nasdaq: EOLS) is a performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Visit us at www.evolus.com and follow us on LinkedIn, Twitter, Instagram or Facebook.

Jeuveau® is a registered trademark of Evolus, Inc.
Hi-Pure is a trademark of Daewoong Pharmaceutical Co, Ltd.

Investor/Media Contact:

David K. Erickson, Evolus, Inc.

Vice President, Investor Relations

Tel: 949-966-1798

Email: david.erickson@evolus.com

Source: Evolus

FAQ

What events will Evolus, Inc. participate in during November 2022?

Evolus will participate in the Stifel 2022 Healthcare Conference on November 15, 2022, and the 5th Annual Evercore ISI HealthCONx Conference on November 30, 2022.

When is the Stifel 2022 Healthcare Conference featuring Evolus, Inc.?

The Stifel 2022 Healthcare Conference is on November 15, 2022, from 8:35 to 9:05 am ET.

What time will Evolus present at the Evercore ISI HealthCONx Conference?

Evolus will present at the Evercore ISI HealthCONx Conference on November 30, 2022, from 11:45 am to 12:05 pm ET.

Where can I find the webcasts for Evolus' conference presentations?

The audio webcasts for Evolus' conference presentations will be available on their investor relations website.

How long will the conference webcasts for Evolus be available for replay?

The conference webcasts will be available for replay for 90 days after the presentations.

Evolus, Inc.

NASDAQ:EOLS

EOLS Rankings

EOLS Latest News

EOLS Stock Data

689.57M
50.17M
12.31%
80.25%
8.35%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
NEWPORT BEACH